Results 291 to 300 of about 115,105 (360)
ACR Open Rheumatology, Volume 8, Issue 1, January 2026.
Mikako Harata, Caitrin Coffey
wiley +1 more source
LPS‐stimulated DC activation upregulated DBC1. DBC1‐deficient DC ameliorated murine SLE symptoms. DBC1 deficiency suppressed immune responses in DC. DBC1 deficiency lowered STAT5 expression and subsequent phosphorylation. STAT5 overexpression abolished murine SLE remission primed by DBC1 deficiency.
Ze Xiu Xiao +9 more
wiley +1 more source
Endocarditis due to <i>Coxiella burnetii</i> in congenital heart disease patients: a clinical case series and diagnostic considerations. [PDF]
Puyana-Rodríguez JM +8 more
europepmc +1 more source
Hydroxychloroquine for the treatment of chronic graft-versus-host disease
Andrew L. Gilman +11 more
openalex +1 more source
ABSTRACT Aim To estimate the prevalence of medication use in nonhospitalized pregnant women with COVID‐19. Methods A prospective two‐stage individual patient meta‐analysis across 10 data sources in Europe and North America studied medication use among nonhospitalized pregnant women with COVID‐19 between January 2020 and December 2022.
Odette de Bruin +72 more
wiley +1 more source
Correction: Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis. [PDF]
europepmc +1 more source
Adjunctive molecular hydrogen therapy for refractory malar rash in systemic lupus erythematosus: A case report with immunological insights. [PDF]
Hsu NS +5 more
europepmc +1 more source
Strategic Preparedness of Broad‐Spectrum Antivirals for Rapid Response Towards Next Pandemics
Nanoengineered broad‐spectrum antivirals (BSAs) represent a transformative approach to pandemic preparedness. Unlike virus‐specific drugs requiring separate development, BSAs act across multiple viral families through nanoengineering strategies that enhance solubility, bioavailability, and host‐targeted activity.
Sanoj Rejinold N +2 more
wiley +1 more source

